Prostate specific antigen density as a p
โ
Alan Pollack; Scott Lankford; Gunar K. Zagars; R. Joseph Babaian
๐
Article
๐
1996
๐
John Wiley and Sons
๐
English
โ 632 KB
## BACKGROUND. The pretreatment serum prostate specific antigen level (PSAL) is the most significant predictor of biochemical and local failure in patients treated with definitive radiotherapy. The role of prostate specific antigen (PSA) density (PSAD) relative to PSAL for such patients is controv